Article Information
History
- August 13, 2021.
Article Versions
- Version 1 (August 7, 2021 - 14:28).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Rajni Kant, Ph.D1,
- Gaurav Dwivedi, Ph.D1,
- Kamran Zaman, MD1,
- Rima R Sahay, MD2,
- Gajanan Sapkal, Ph.D2,
- Himanshu Kaushal, Ph.D2,
- Dimpal A. Nyayanit, Ph.D2,
- Pragya D Yadav, Ph.D2,*,
- Gururaj Deshpande, Ph.D2,
- Rajeev Singh, Ph.D1,
- Sandeep Chaowdhary, Ph.D3,
- Nivedita Gupta, Ph.D4,
- Sanjay Kumar, MCh5,
- Priya Abraham, Ph.D2,
- Samiran Panda, MD, DTM&H4 and
- Balram Bhargava, DM4
- 1Indian Council of Medical Research-Regional Medical Research Centre (RMRC), Gorakhpur, Uttar Pradesh, India, Pin-273013
- 2Indian Council of Medical Research-National Institute of Virology (ICMR-NIV), Pune, Maharashtra, India, Pin-411021
- 3Chief Medical Officer, Community Health Centre, Siddarthnagar, Uttar Pradesh, India, Pin-272207
- 4Indian Council of Medical Research, V. Ramalingaswami Bhawan, P.O. Box No. 4911, Ansari Nagar, New Delhi, India Pin-110029
- 5Command Hospital (Southern Command), Armed Forces Medical College, Pune, Maharashtra, India Pin-411040
- ↵*Corresponding author
Dr Pragya D. Yadav, Scientist ‘E’ and Group Leader, Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Sus Road, Pashan, Pune, Maharashtra, India Pin-411021., Phone: +9120-26006111, Fax No. 91-20-26122669, Email: hellopragya22{at}gmail.com
Posted August 13, 2021.
Serendipitous COVID-19 Vaccine-Mix in Uttar Pradesh, India: Safety and Immunogenicity Assessment of a Heterologous Regime
